SPECT/CT Imaging of Pluronic Nanocarriers with Varying Poly(ethylene oxide) Block Length and Aggregation State
Alexandra Arranja (External organisation)
Oleksandra Ivashchenko ( University Medical Centre Utrecht, MILabs B.V., TU Delft - RST/Biomedical Imaging)
Antonia G. Denkova (TU Delft - RST/Applied Radiation & Isotopes)
Karolina Morawska (Universiteit Gent)
Sandra Van Vlierberghe (Universiteit Gent)
Peter Dubruel (Universiteit Gent)
Gilles Waton (Institut Charles Sadron)
Freek J. Beekman (MILabs B.V., University Medical Centre Utrecht, TU Delft - RST/Biomedical Imaging)
François Schosseler (Institut Charles Sadron)
Eduardo Mendes (TU Delft - ChemE/Advanced Soft Matter)
More Info
expand_more
Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.
Abstract
Optimal biodistribution and prolonged circulation of nanocarriers improve diagnostic and therapeutic effects of enhanced permeability and retention-based nanomedicines. Despite extensive use of Pluronics in polymer-based pharmaceuticals, the influence of different poly(ethylene oxide) (PEO) block length and aggregation state on the biodistribution of the carriers is rather unexplored. In this work, we studied these effects by evaluating the biodistribution of Pluronic unimers and cross-linked micelles with different PEO block size. In vivo biodistribution of 111In-radiolabeled Pluronic nanocarriers was investigated in healthy mice using single photon emission computed tomography. All carriers show fast uptake in the organs from the reticuloendothelial system followed by a steady elimination through the hepatobiliary tract and renal filtration. The PEO block length affects the initial renal clearance of the compounds and the overall liver uptake. The aggregation state influences the long-term accumulation of the nanocarriers in the liver. We showed that the circulation time and elimination pathways can be tuned by varying the physicochemical properties of Pluronic copolymers. Our results can be beneficial for the design of future Pluronic-based nanomedicines.